Kuu WY[au] - Search Results

Year	Number of Results
1983	1
1985	1
1990	1
1995	1
2003	1
2005	1
2006	1
2007	1
2009	2
2010	1
2011	2
2013	1
2014	1
2023	0

1

Gap-freezing approach for shortening the lyophilization cycle time of pharmaceutical formulations-demonstration of the concept.

Kuu WY, Doty MJ, Rebbeck CL, Hurst WS, Cho YK. Kuu WY, et al. J Pharm Sci. 2013 Aug;102(8):2572-88. doi: 10.1002/jps.23610. Epub 2013 May 31. J Pharm Sci. 2013. PMID: 23728733

2

Modeling of heat and mass transfer processes for the gap-lyophilization system using the mannitol-trehalose-NaCl formulation.

Kuu WY, Doty MJ, Nisipeanu E, Rebbeck CL, Cho YK, Smit MH. Kuu WY, et al. J Pharm Sci. 2014 Sep;103(9):2784-2796. doi: 10.1002/jps.23923. Epub 2014 Mar 19. J Pharm Sci. 2014. PMID: 24648334

3

Correlation of laboratory and production freeze drying cycles.

Kuu WY, Hardwick LM, Akers MJ. Kuu WY, et al. Int J Pharm. 2005 Sep 30;302(1-2):56-67. doi: 10.1016/j.ijpharm.2005.06.022. Int J Pharm. 2005. PMID: 16099610

4

Comparison of simulated and in-vivo plasma levels of cilastatin following intravenous in-line drug administration.

Wong J, Kuu WY, Burke R, Johnson R, Wood RW. Wong J, et al. Among authors: kuu wy. Pharm Res. 1995 Jan;12(1):144-8. doi: 10.1023/a:1016263426153. Pharm Res. 1995. PMID: 7724477

5

Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study.

Mockus LN, Paul TW, Pease NA, Harper NJ, Basu PK, Oslos EA, Sacha GA, Kuu WY, Hardwick LM, Karty JJ, Pikal MJ, Hee E, Khan MA, Nail SL. Mockus LN, et al. Among authors: kuu wy. Pharm Dev Technol. 2011 Nov-Dec;16(6):549-76. doi: 10.3109/10837450.2011.611138. Epub 2011 Sep 20. Pharm Dev Technol. 2011. PMID: 21932931

6

Improving immobilized biocatalysts by gel phase polymerization.

Kuu WY, Polack JA. Kuu WY, et al. Biotechnol Bioeng. 1983 Aug;25(8):1995-2006. doi: 10.1002/bit.260250810. Biotechnol Bioeng. 1983. PMID: 18551546

7

Product mass transfer resistance directly determined during freeze-drying cycle runs using tunable diode laser absorption spectroscopy (TDLAS) and pore diffusion model.

Kuu WY, O'Bryan KR, Hardwick LM, Paul TW. Kuu WY, et al. Pharm Dev Technol. 2011 Aug;16(4):343-57. doi: 10.3109/10837451003739263. Epub 2010 Sep 17. Pharm Dev Technol. 2011. PMID: 20387998

8

Rapid determination of vial heat transfer parameters using tunable diode laser absorption spectroscopy (TDLAS) in response to step-changes in pressure set-point during freeze-drying.

Kuu WY, Nail SL, Sacha G. Kuu WY, et al. J Pharm Sci. 2009 Mar;98(3):1136-54. doi: 10.1002/jps.21478. J Pharm Sci. 2009. PMID: 18683861

9

Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles.

Kuu WY, Hardwick LM, Akers MJ. Kuu WY, et al. Int J Pharm. 2006 Apr 26;313(1-2):99-113. doi: 10.1016/j.ijpharm.2006.01.036. Epub 2006 Feb 28. Int J Pharm. 2006. PMID: 16513303

10

Determination of in-process limits during parenteral solution manufacturing using Monte Carlo Simulation.

Kuu WY, Chilamkurti R. Kuu WY, et al. PDA J Pharm Sci Technol. 2003 Jul-Aug;57(4):263-76. PDA J Pharm Sci Technol. 2003. PMID: 14558700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results